Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (15 quarters reported)
$294M in Q4 2022 → $1.91M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Mdxhealth Sa | 100.0% | Unchanged | 4,700,457 | $1.91M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 15, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 17, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 14, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Paragon 28 Inc | Exited | −4,854,882 | −$63.4M | — |
| Optinose Inc | Exited | −973,684 | −$8.91M | — |
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Paragon 28 Inc | Trimmed | −5,531,263 | −$72.2M | 80.4% |
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Optinose Inc | Exited | −14,605,263 | −$9.53M | — |
| Optinose Inc | New | +973,684 | +$6.36M | 5.1% |
| Paragon 28 Inc | Trimmed | −500,000 | −$5.15M | 86.0% |
quarter ended September 30, 2024 · filed November 01, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mdxhealth Sa | Added | +150,000 | +$310K | 10.6% |
Loading...
